Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors

Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors

US Patent 12491202 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Radiohalogenated agents for in situ immune modulated cancer vaccination2024
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination2023
Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunot2023
Long-lived gadolinium based tumor targeted imaging and therapy agents2023
Luminescent phospholipid analogs for the identification and isolation of circula2022
Phospholipid ether analogs as cancer-targeting drug vehicles2022
Radioactive phospholipid metal chelates for cancer imaging and therapy2021
Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2021
Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2021
Phospholipid ether analogs for imaging and targeted treatment of pediatric solid2021